• LAST PRICE
    1.3000
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    1.3000/ 2
  • Ask / Lots
    1.6900/ 2
  • Open / Previous Close
    --- / 1.3000
  • Day Range
    ---
  • 52 Week Range
    Low 1.0509
    High 3.5500
  • Volume
    10
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 1.3
TimeVolumeTRIB
09:32 ET2411.28
09:44 ET19991.3
10:20 ET5001.32
10:56 ET20001.3089
10:58 ET7451.3
11:02 ET2501.29
11:18 ET16051.3
11:27 ET33961.3
11:34 ET1001.28
11:38 ET1001.28
12:08 ET3001.28
12:46 ET6001.2895
01:09 ET2321.29
01:42 ET3501.28
01:47 ET1001.285
02:00 ET12101.28
02:18 ET5001.28
02:45 ET1901.28
02:56 ET10001.285
03:08 ET4001.283
03:10 ET18881.283
03:33 ET6001.2802
03:39 ET1501.29
03:55 ET1001.28
04:00 ET1901.3
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesTRIB
Trinity Biotech PLC
14.8M
-0.6x
---
United StatesRVP
Retractable Technologies Inc
17.9M
-1.1x
---
United StatesUTRS
Minerva Surgical Inc
10.0
0.0x
---
United StatesSONXD
Sonendo Inc
953.2K
0.0x
---
United StatesDHAI
DIH Holding US Inc
40.5M
-5.3x
---
United StatesDFCO
Dalrada Financial Corp
4.9M
-0.2x
---
As of 2024-11-22

Company Information

Trinity Biotech plc is an Ireland-based commercial stage biotechnology company. The Company is focused on human diagnostics and diabetes management solutions, including wearable biosensors. The Company develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market and has also entered the wearable biosensor industry. It intends to develop a range of biosensor devices and related services, starting with a continuous glucose monitoring product. Its products are used to detect infectious diseases and to quantify the level of Hemoglobin A1c and other chemistry parameters in serum, plasma and whole blood. The Company, through EpiCapture Limited, is also developing a non-invasive test for monitoring the risk of aggressive prostate cancer. The Company sells its products direct in the United States and through a network of international distributors.

Contact Information

Headquarters
Ida Business Park, Bray, Co WicklowDUBLIN, Ireland 18
Phone
---
Fax
---

Executives

President, Chief Executive Officer, Executive Director
John Gillard
Founder, Executive Director
Ronan O'caoimh
Chief Financial Officer, Chief Accounting Officer
Louise Tallon
Chief Technology Officer
Gary Keating
Chief Information Officer
Eibhlin Kelly

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$14.8M
Revenue (TTM)
$59.1M
Shares Outstanding
2.3M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.04
EPS
$-2.32
Book Value
$-15.67
P/E Ratio
-0.6x
Price/Sales (TTM)
0.3
Price/Cash Flow (TTM)
---
Operating Margin
-22.71%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.